Sensorineural hearing loss
Drug research and approvals for sensorineural hearing loss: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 91 studies of sensorineural hearing loss are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 1 approved and 3 open orphan designations naming it.
- Recruiting worldwide: 91
- Trials authorized in Canada: 5
- FDA orphan approvals: 1
- EU medicines: 0
Recruiting Now
Newest start dates first, of 91 recruiting on ClinicalTrials.gov ↗- A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher…NCT07710196 · Phase 3 · Nacuity Pharmaceuticals, Inc. · starts Oct 23, 2026
- Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.NCT07697911 · Not reported · MED-EL Elektromedizinische Geräte GmbH · starts Oct 19, 2026
- Auditory Intranerve Stimulation Perceptual StudyNCT07789665 · Not applicable · Hannover Medical School · starts Aug 1, 2026
- Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction…NCT07130136 · Not applicable · Cochlear · starts Jul 24, 2026
- Hidden Hearing Loss in Older AdultsNCT07646119 · Not reported · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · starts Jun 15, 2026
- Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing LossNCT07627971 · Phase 1 / Phase 2 · Skylark Bio Inc. · starts May 28, 2026
- First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing LossNCT07637981 · Phase 2 · Dendrogenix · starts May 13, 2026
- Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus InfectionNCT07635368 · Not reported · Copenhagen University Hospital, Rigshospitalet · starts Apr 21, 2026
- Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual PerformanceNCT07548944 · Not reported · Okuvision GmbH · starts Apr 20, 2026
- Alpha-Tectorin, Interleukin-10 and Thiol-Disulfide Homeostasis in Children With Congenital Hearing LossNCT07860580 · Not reported · Harran University · starts Apr 20, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Sep 25, 2026 | A trial of aavanc80-hotof gene therapy in individuals with sensorineural hearing loss due to otoferlin gene (otof) mutationsAAVANC80-HOTOF | Eli Lilly | Pending |
| May 1, 2026 | Usability of the intracochlear catheter incat a pilot feasability studyDEXAMETHASONE / N-ACETYLCYSTEINE / TRIAMCINOLONE | SUNNYBROOK RESEARCH INSTITUTE | Pending |
| Nov 29, 2024 | Usability of the intracochlear catheter incat - a pilot feasibility studyDEXAMETHASONE / TRIAMCINOLONE / ACETYLCYSTEINE | SUNNYBROOK RESEARCH INSTITUTE | Pending |
| Nov 15, 2024 | A phase I/ii clinical trial with sens-501 in children suffering from severe to profound hearing loss due to otoferlin (otof) mutationsSENS-501 | SENSORION | Pending |
| Sep 28, 2018 | A two-part, randomised, double-blind, placebo-controlled, parallel-group, efficacy and safety study of sens-401 in subjects with severe or profound sudden…AZASETRON (SENS-401) | SENSORION | Closed |
FDA Orphan Designations
Approved first, then open designations, newest first| Apr 23, 2026 | Otarmenitreatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any frequency >90 dB HL)… | Regeneron Pharmaceuticals, Inc. | Approved |
| May 10, 2021 | 6-fluoro-9-methyl-9H-pyrido[3,4-b]-indoleTreatment of Sudden Sensorineural Hearing Loss | AudioCure Pharma GmbH | Designated |
| Dec 12, 2019 | pioglitazoneTreatment of sudden sensorineural hearing loss | Strekin AG | Designated |
| Mar 28, 2006 | (UDU-stereoisomer of c-UJUun UNU-terminal UkUnhibitor)Treatment of acute sensorineural hearing loss | Altamira Therapeutics Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA